US 7368106
Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state
granted A61KA61K2039/505A61K38/2013
Quick answer
US patent 7368106 (Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K38/2013, A61K39/395